10-K Filing

Company

INTEGRATED BIOPHARMA INC

Filed

October 15, 2012

Period of Report

June 30, 2012

Accession Number

0001016504-12-000022

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →